OMIC Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.55% compare to its pairs and should correct upwards.

Stats
Today's Volume	18 861
Average Volume	5 536
Market Cap	20.87M
EPS	$-0.340 ( Q1 \| 2024-05-14 )
Next earnings date	( $-8.88 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.220 (Sector) 42.63 (Industry) 78.56
ATR14	$0.222 (2.61%)

GCTK 0.50%

GMVDW -1.13%

LUCY 50.00%

LUCYW 2.97%

NXGLW 0.00%

NYXH -0.57%

OMIC -9.33%

POCI 0.51%

Insider Trading

Date	Person	Action	Amount	type
2024-06-15	Meeter Dalen	Buy	6 250	Common Stock
2024-06-15	Meeter Dalen	Sell	6 250	Restricted Stock Units
2024-06-15	Glezer Eli N.	Buy	7 500	Common Stock
2024-06-15	Glezer Eli N.	Sell	7 500	Restricted Stock Units
2024-06-15	Spaventa Andrew	Buy	14 584	Common Stock

INSIDER POWER
44.10
Last 98 transactions
Buy: 5 152 178 \| Sell: 2 090 858

Correlation (AI algo v.1.1b): Undervalued: 0.55% $8.55 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.04 (neutral)

Short: -0.54 (weak negative)

Signal:(36.887) Neutral

Singular Genomics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Singular Genomics Correlation - Currency/Commodity

-0.16
( neutral )

-0.39
( neutral )

0.04
( neutral )

-0.11
( neutral )

-0.39
( neutral )

0.53
( weak )

Singular Genomics Financials

Annual	2023
Revenue:	$2.91M
Gross Profit:	$-558 000 (-19.17 %)
EPS:	$-1.300

FY	2023
Revenue:	$2.91M
Gross Profit:	$-558 000 (-19.17 %)
EPS:	$-1.300

FY	2022
Revenue:	$765 000
Gross Profit:	$-24 000.00 (-3.14 %)
EPS:	$-1.240

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.377

Financial Reports:

No articles found.

Singular Genomics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Singular Genomics

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.